Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial

Haiping Chen, Zhuoying Huang, Shaoying Chang, Mei Mei Hu, Qing‐Bin Lu, Yuntao Zhang, Hui Wang, Yanhui Xiao, Hui Wang, Yonghong Ge, Yong Zou, Fuqiang Cui, Shasha Han, Min Zhang, Shengyi Wang, Xiaoping Zhu, Biao Zhang, Zhi Li, Jia Ren, Xiao Chen, Rui Ma, Lei Zhang, Guo Xue, Linyun Luo, Xiaodong Sun, Xiaoming Yang